Trajan Wealth’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,561
| Closed | -$213K | – | 176 |
|
|
2024
Q4 | $213K | Buy |
+1,561
| New | +$213K | 0.01% | 162 |
|
|
2024
Q3 | – | Sell |
-1,455
| Closed | -$200K | – | 187 |
|
|
2024
Q2 | $200K | Sell |
1,455
-120
| -8% | -$16.5K | 0.01% | 160 |
|
|
2024
Q1 | $217K | Buy |
+1,575
| New | +$217K | 0.01% | 176 |
|